Your browser doesn't support javascript.
loading
Bone Disease in Mastocytosis.
Orsolini, Giovanni; Viapiana, Ombretta; Rossini, Maurizio; Bonifacio, Massimiliano; Zanotti, Roberta.
Afiliação
  • Orsolini G; Rheumatology Unit, University of Verona, Verona, Italy. Electronic address: giovanniorsolini@gmail.com.
  • Viapiana O; Rheumatology Unit, University of Verona, Verona, Italy.
  • Rossini M; Rheumatology Unit, University of Verona, Verona, Italy.
  • Bonifacio M; Hematology Unit, University of Verona, Verona, Italy.
  • Zanotti R; Hematology Unit, University of Verona, Verona, Italy.
Immunol Allergy Clin North Am ; 38(3): 443-454, 2018 08.
Article em En | MEDLINE | ID: mdl-30007462
ABSTRACT
Systemic mastocytosis can give very different bone pictures from osteosclerosis to osteoporosis. Osteoporosis is one of the most frequent manifestations particularly in adults and the most clinical relevant. It is often complicated by a high recurrence of mainly vertebral fragility fractures. The main factor of bone loss is the osteoclast with a relative or absolute predominance of bone resorption. The RANK-RANKL pathway seems of key importance, but histamine and other cytokines also play a significant role in the process. The predominance of resorption made bisphosphonates, as anti-resorptive drugs, the most rational treatment of bone involvement in systemic mastocytosis.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osteoclastos / Doenças Ósseas / Mastocitose Sistêmica Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osteoclastos / Doenças Ósseas / Mastocitose Sistêmica Idioma: En Ano de publicação: 2018 Tipo de documento: Article